不同透析器评估及白蛋白预冲对低抗凝间歇性血液透析的影响
该交叉研究纳入10例患者,在7种不同设置下进行4小时透析,用三维CT量化透析器纤维阻塞。结果显示,减少抗凝时Solacea透析器开放纤维比例不受影响,优于FX800和Evodial;白蛋白预冲未改善透析器通畅性。
要点
- 低抗凝需求时,Solacea透析器纤维通畅性优于FX800和Evodial。
- 白蛋白预冲未改善FX800和Evodial的透析器通畅性。
- 无因凝血提前中断的透析 session。
核心结论
- 在需要减少抗凝的情况下,不对称三醋酸纤维素ATA Solacea透析器优于传统聚砜膜FX800和肝素涂层聚丙烯腈膜Evodial。
- 使用人白蛋白预冲透析管路未改善透析器通畅性。
研究设计与样本
- 交叉研究,纳入10例患者,每周中期进行4小时血液透析,共7种设置。
- 设置包括Solacea 19H和FX800各用常规和半量抗凝、Evodial 1.3无全身抗凝,以及FX800半量抗凝和Evodial无抗凝时用人白蛋白溶液预冲。
- 用三维CT扫描技术以微米分辨率可视化透析器出口灌封处的纤维阻塞。
主要发现
- 无session因管路凝血而提前中断。
- Solacea透析后开放纤维相对数量不受抗凝减少影响,优于FX800减量抗凝和Evodial无抗凝。
- FX800和Evodial有无白蛋白预冲时开放纤维相对数量无差异。
临床怎么用
- 在需减少抗凝的间歇性血液透析中,可优先选择Solacea透析器以维持纤维通畅性。
- 不推荐常规使用人白蛋白预冲来改善透析器通畅性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Systemic anticoagulation is widely used in routine clinical hemodialysis, but can be contraindicated in specific settings. Anticoagulant-free treatment regimens are prone to failure even in chronic intermittent hemodialysis. We quantified fiber blocking in settings of reduced anticoagulation to assess performance of different dialyzers and the potential benefit of albumin priming. METHODS: This crossover study included 10 patients performing 4 hours of hemodialysis at midweek in 7 different settings: that is, using Solacea 19H and FX800, both with regular and half dose of anticoagulation, Evodial 1.3 without systemic anticoagulation, and FX800 (half dose) and Evodial (no anticoagulation) when primed with a human albumin solution. Dialyzer fiber blocking was visualized in the dialyzer outlet potting using a 3-dimensional computed tomography (CT) scanning technique on micrometer resolution. RESULTS: No sessions had to be prematurely interrupted because of circuit clotting. The relative number of open fibers post dialysis was not influenced by the reduction of anticoagulation in the Solacea making this dialyzer superior in fiber patency in this setting above both the FX800 with reduced anticoagulation and the Evodial with no anticoagulation. Furthermore, no differences in relative number of open fibers were found in the FX800 and Evodial dialyzers with versus without albumin priming. CONCLUSION: In situations in which reduced anticoagulation is indicated, the asymmetric triacetate ATA Solacea dialyzer outperforms a dialyzer with a conventional polysulfone membrane (FX800) or with the heparin-coated polyacrylonitrile membrane (Evodial). The use of human albumin to prime the dialysis circuit did not improve dialyzer patency.
引用
- Vanommeslaeghe F, De Somer F, Josipovic I, et al. Evaluation of Different Dialyzers and the Impact of Predialysis Albumin Priming in Intermittent Hemodialysis With Reduced Anticoagulation. Kidney Int Rep. 2019. PMID: 31890995. doi:10.1016/j.ekir.2019.07.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。